Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
01/2008
01/08/2008US7316913 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls
01/08/2008US7316911 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases
01/08/2008US7316900 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer
01/08/2008US7316818 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
01/08/2008CA2439291C Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists
01/08/2008CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
01/08/2008CA2408602C Phenylglycine derivatives
01/08/2008CA2402668C Use of cdp-choline for the prophylactic treatment of cerebral ischemia
01/08/2008CA2218145C Method of treating dilated cardiomyopathy
01/07/2008CA2551578A1 Lignan complex derived from flax seed used for treatment of hypercholesterolemic atherosclerosis
01/03/2008WO2008003028A2 Pharmaceutical compositions comprising droxidopa
01/03/2008WO2008002905A2 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
01/03/2008WO2008002683A2 Polymorphous forms of carvedilol phosphate
01/03/2008WO2008002576A2 Prolyl hydroxylase inhibitors and methods of use
01/03/2008WO2008001959A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof
01/03/2008WO2008001930A1 Pyridylisoxazole derivative
01/03/2008WO2008001912A1 Substituted benzyl ester derivative and use thereof
01/03/2008WO2008001884A1 Antiarteriosclerosis agents
01/03/2008WO2008001883A1 α-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT
01/03/2008WO2008001734A1 Compressed preparation
01/03/2008WO2008001134A1 1,2,3,8,9,9a-hexahydro-7h-benzo(de)-1,7-naphthyridin-7-one derivatives as inhibitors of poly(adp-ribose) polymerase (parp)
01/03/2008WO2008000968A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same
01/03/2008WO2008000967A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same
01/03/2008WO2008000951A2 Urea derivatives of tropane, their preparation and their therapeutic application
01/03/2008WO2008000744A2 2-0'-methyladen0sine derivatives and their use as agonists or antagonists of an adenosine receptor
01/03/2008WO2008000186A1 A method for identifying novel gene and the resulting novel genes
01/03/2008WO2008000166A1 Granule and preparation method thereof
01/03/2008WO2008000040A1 A stabilised composition comprising ace inhibitors
01/03/2008WO2007123984A3 Pre-mixed, ready-to-use pharmaceutical compositions
01/03/2008WO2007120600A3 3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
01/03/2008WO2007117961A3 Renin inhibitors
01/03/2008WO2006113942A3 Method of inhibiting cathepsin activity
01/03/2008US20080004333 Ion channel modulating compounds and uses thereof
01/03/2008US20080004322 Methods of food intake management
01/03/2008US20080004318 Substituted Bicyclic and Tricyclic Thrombin Receptor Antagonists
01/03/2008US20080004315 Guanidine Derivatives and Therapeutic Uses Thereof
01/03/2008US20080004312 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
01/03/2008US20080004309 [(2-bromo-4-hydroxy-1-phenyl-1H-pyrrolo[2,3-c]pyridine-5-carbonyl)-amino]-acetic acid; modulates the stability and/or activity of hypoxia inducible factor (HIF)
01/03/2008US20080004301 Benzene Compound Having 2 or More Substituents
01/03/2008US20080004295 Novel compounds
01/03/2008US20080004293 Adenosine receptor antagonists and methods of making and using the same
01/03/2008US20080004262 2,2,7,9-tetramethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-3-ol; 3-hydroxy-2,2,9-trimethyl-4-[(2-phenylethyl)amino]-3,4-dihydro-2H-pyrano[2,3-g]quinolin-7-carbonitrile; have the prolongation effect on refractory period
01/03/2008US20080004257 Kinase inhibitors
01/03/2008US20080004251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor
01/03/2008US20080004210 Diagnostic markers for ischemia
01/03/2008US20080004207 Use of hmgb1 for protection against ischemia reperfusion injury
01/03/2008US20080003675 Methods and compositions for identifying morphogen analogs
01/03/2008US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases
01/03/2008US20080003285 Immediate Release Pharmaceutical Tablets With Height Greater Than Width
01/03/2008US20080003269 Poncirus Trifoliata Extract for Preventing and Treating Ischemic Heart Diseases and Pharmaceutical Composition and Health Food Containing the Same
01/03/2008US20080003266 Composition Comprising Statins
01/03/2008US20080003254 Systems and methods for delivering a rapamycin analog that do not inhibit human coronary artery endothelial cell migration
01/03/2008US20080003206 ABCB5 positive mesenchymal stem cells as immunomodulators
01/03/2008US20080003199 IL-33 in the treatment and diagnosis of diseases and disorders
01/03/2008US20080003179 Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis
01/03/2008DE102006031314A1 Use of 1,4-diaryl-dihydropyrimidin-2-one derivative for producing a medicament for the treatment and/or prophylaxis of e.g. pulmonary arterial hypertension, chronic-obstructive lung diseases and sleep apnea syndrome
01/03/2008CA2787343A1 Compositions comprising modified lcat and uses thereof
01/03/2008CA2656159A1 Pyridylisoxazole derivatives
01/03/2008CA2655913A1 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility
01/03/2008CA2654986A1 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
01/03/2008CA2654414A1 Granule and preparation method thereof
01/03/2008CA2654371A1 Therapeutic compounds
01/03/2008CA2653382A1 A stabilised composition comprising ace inhibitors
01/03/2008CA2648769A1 Urea derivatives of tropane, their preparation and their therapeutic application
01/02/2008EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof
01/02/2008EP1873154A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF
01/02/2008EP1873153A1 Heterocyclic compound
01/02/2008EP1873148A1 pharmaceutical compositions containing crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid
01/02/2008EP1873140A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them
01/02/2008EP1873139A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them
01/02/2008EP1872797A2 Treatment of cardiovascular and related pathologies
01/02/2008EP1872785A1 pharmaceutical composition comprising condensed indole compound
01/02/2008EP1872782A1 Drug for treating or diagnosing vascular lesion in the skin or the subcutaneous soft tissue caused by light irradiation
01/02/2008EP1871773A1 N-[3-(1-amino-5,6,7,8-tetrahydro-2,4,4b-triazafluoren-9-yl)-phenyl]benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase
01/02/2008EP1871758A1 Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers
01/02/2008EP1871398A1 Use of a biological active blood serum for the treatment of stroke
01/02/2008EP1871392A1 Modulating angiogenesis with nod factors such as glucosamine oligosaccharides
01/02/2008EP1871367A2 Compounds for treating inflammatory and demyelinating diseases
01/02/2008EP1435986B1 Igf-binding protein-derived peptide
01/02/2008EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor
01/02/2008EP1406859B1 Substituted 4-aminocyclohexanol derivatives
01/02/2008EP1381380B1 Pharmaceutical composition containing bulbophyllum
01/02/2008EP1381376B1 Water-absorbent polymers and their use
01/02/2008EP1268404B1 Malonamic acids and derivatives thereof as thyroid receptor ligands
01/02/2008EP1263739B1 Crystalline salts of 7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino pyrimidin-5-yl -(3r,5s)-3,5-dihydroxyhept-6-enoic acid
01/02/2008EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use
01/02/2008EP1121116B1 Sustained release pharmaceutical composition of fluvastatin
01/02/2008EP1100870B1 Improvement of cardiac function by mesenchymal stem cell transplantation
01/02/2008CN101098861A Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators
01/02/2008CN101098709A Use of a trpc channel for the treatment of a cardiovascular disease
01/02/2008CN101098702A Drugs, food or drink for improving pancreatic functions
01/02/2008CN101098698A 5-carboxamido substitued thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family
01/02/2008CN101098689A Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor
01/02/2008CN101096363A 2,4,5-three-substituted thiazole compound, preparation method, medicament composition and pharmacy use thereof
01/02/2008CN101096348A New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them
01/02/2008CN101096347A New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them
01/02/2008CN101096346A New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them
01/02/2008CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
01/02/2008CN101095956A Scutellarin prodrug using carboxymethyl chitosan as the carrier and method for preparing the same
01/02/2008CN101095955A Scutellarin prodrug using poly-aspartate derivant as the carrier and method for preparing the same